PMV Pharmaceuticals is collaborating with MD Anderson Cancer Center (MDACC) and Memorial Sloan Kettering Cancer Center (MSK) to support an investigator-initiated Phase 1b study evaluating rezatapopt ...

U.S. equities finished higher during the third quarter, with 10 of 11 GICS sectors posting positive returns. Click here to ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Utilization in fine chemical synthesis processes for the production of specialty chemicals and intermediates drives <a ...

During the monitoring period, after the seasonal influenza period had ended, 59 wastewater treatment plants showed increases ...

We recently compiled a list of the 8 Best US Stocks For Foreign Investors Right Now. In this article, we are going to take a ...

Merck reported positive results for its experimental treatment designed to protect infants from RSV. The mid to late-stage ...

We recently published a list of 10 Most Promising Low-Cost Stocks According to Hedge Funds. In this article, we are going to ...

In a late-stage trial, the medicine performed better than Merck's Keytruda in treating non-small cell lung ... And the numbers speak for themselves: Amazon: if you invested $1,000 when we doubled down ...

Merck's P/S multiple is roughly 4, and its P/FCF is 21. That makes its valuation a bit pricier than Pfizer's per dollar of revenue, but significantly cheaper per dollar of free cash flow. In other ...

The Fund returned 7.38% versus 5.89% for the S&P 500 Index for the quarter, and 12.86% since inception versus 10.67% for the ...

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...